Skip to content
Clinical Trials – home
ItalyBack to Italy

Clinical trials in Pontedera

8 clinical trials in Pontedera, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Pontedera at a glance
8
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

8 trials in Pontedera

Open in trial search

Crohn's disease

Recruiting
Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Tulisokibart
  • Sponsor:Merck Sharp & Dohme LLC
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Unicancer
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:ItalyItaly
  • Participants:0–17 years
  • Substances:Amoxicillin
  • Sponsor:Istituto Di Ricovero E Cura A Carattere Scientifico Materno Infantile Burlo Garofolo

Crohn's disease

Not recruiting
Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Tulisokibart
  • Sponsor:Merck Sharp & Dohme LLC
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:IRCCS Ospedale Policlinico San Martino
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Stemline Therapeutics Inc.

Crohn's disease

Not recruiting
InvestigationalNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Guselkumab
  • Sponsor:Janssen - Cilag International

Other cities in Italy

The busiest research cities in the country

All 232 cities in Italy

Clinical research in Pontedera

What the registry says about research in the country

01 Breast Cancer Research

Advanced clinical trials focusing on estrogen receptor-positive breast cancer treatment strategies, specifically targeting patients with high-risk node-positive disease.

  • Novel Endocrine Therapy Evaluation
  • HER2-negative Disease Management
  • Early-stage Treatment Optimization

Investigating innovative therapeutic approaches to improve breast cancer-free survival rates.

02 Treatment Timing Studies

Comprehensive research examining the optimal timing of chemotherapy and aromatase inhibitors in post-menopausal breast cancer patients.

  • Sequential Treatment Protocols
  • Concurrent Therapy Assessment
  • Endocrine Response Evaluation

Analyzing treatment sequences to prevent disease recurrence in early-stage breast cancer.

03 Endocrine-Responsive Cancer

Studies focused on the 80% of breast cancers that show endocrine responsiveness, investigating optimal treatment integration strategies.

  • Treatment Integration Methods
  • Recurrence Risk Management
  • Long-term Outcome Assessment

Developing evidence-based approaches for combining multiple treatment modalities.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.